Connection

Juan Horcajada to Prospective Studies

Back to Details
This is a "connection" page, showing publications Juan Horcajada has written about Prospective Studies.
Juan Horcajada
Connection Strength
0.109
Prospective Studies
  1. Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical. J Infect. 2019 09; 79(3):253-261.
    View in: PubMed
    Score: 0.033
  2. Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients? Molecules. 2019 Feb 01; 24(3).
    View in: PubMed
    Score: 0.032
  3. Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate. Int J Antimicrob Agents. 2016 Dec; 48(6):725-727.
    View in: PubMed
    Score: 0.028
  4. Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia. J Antimicrob Chemother. 2019 11 01; 74(11):3268-3273.
    View in: PubMed
    Score: 0.009
  5. Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections. Antimicrob Agents Chemother. 2017 08; 61(8).
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.